The United States commemorates National Hepatitis Awareness Month each May, and May 19 is designated as Hepatitis Testing Day. Viral hepatitis still persists as a major public health threat despite availability of preventive measures such as vaccines and therapies, including a curative treatment for hepatitis C virus (HCV) infection.

New cases of hepatitis B virus (HBV) and HCV infections are on the rise, largely among persons who inject drugs, with some attributed to the current U.S. opioid epidemic ([@R1]). Recent hepatitis A outbreaks have also occurred among unvaccinated injection drug users and homeless persons ([@R2]). Since August 2016, CDC has responded to hepatitis A outbreaks with high HBV/HCV co-infection, hospitalization, and mortality rates in multiple states (<https://www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm>). New cases of perinatal HBV infection also continue ([@R1]); recently, CDC updated recommendations to strengthen vaccination among newborns and manage pregnant women ([@R3]).

This issue of *MMWR* includes an article about the promising outcomes of three HBV programs that implemented community-based services to improve HBV testing, linkage to care, and treatment among persons born in intermediate-high prevalence countries ([@R4]).
